Results for primary bypass versus primary angioplasty/stent for intermittent claudication due to superficial femoral artery occlusive disease

Journal of Vascular Surgery

Volumn 55, Issue 4, 2012, Pages 1001-1007

  Siracuse, Jeffrey J ^a   Giles, Kristina A ^a   Pomposelli, Frank B ^a   Hamdan, Allen D ^a   Wyers, Mark C ^a   Chaikof, Elliot L ^a   Nedeau, April E ^a   Schermerhorn, Marc L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; AMPUTATION; ARTICLE; COMORBIDITY; DEMOGRAPHY; DISEASE CLASSIFICATION; FALSE ANEURYSM; FEMALE; FEMORAL ARTERY; FEMOROPOPLITEAL BYPASS; FOLLOW UP; HEMATOMA; HUMAN; INTERMETHOD COMPARISON; INTERMITTENT CLAUDICATION; ISRAEL; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIOPERATIVE PERIOD; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RECURRENT DISEASE; REOPERATION; RESTENOSIS; STENT; SURGICAL INFECTION; SURGICAL MORTALITY; TREATMENT OUTCOME; VASCULAR PATENCY;

AGED; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; COHORT STUDIES; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; INTERMITTENT CLAUDICATION; LENGTH OF STAY; LIMB SALVAGE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY; VASCULAR SURGICAL PROCEDURES;

EID: 84859164952     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2011.10.128     Document Type: Article

References (32)

1. M.L. Schermerhorn, J.L. Cronenwett, J.C. Baldwin Open surgical repair versus endovascular therapy for chronic lower-extremity occlusive disease Annu Rev Med 54 2003 269 283
2. K.J. Stewart, W.R. Hiatt, J.G. Regensteiner, A.T. Hirsch Exercise training for claudication N Engl J Med 347 2002 1941 1951
3. L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, F.G. Fowkes Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) J Vasc Surg 45 Suppl S 2007 S5 S67
4. S.P. Nicola, E.J. Hendriks, M.H. Prins, J.A. Teijink EXITPAD study group Optimizing supervised exercise therapy for patients with intermittent claudication J Vasc Surg 52 2010 1226 1233
5. J. Byrne, R.C. Darling 3rd, B.B. Chang, P.S. Paty, P.B. Kreienberg, W.E. Lloyd Infrainguinal arterial reconstruction for claudication: is it worth the risk? An analysis of 409 procedures J Vasc Surg 29 1999 259 267 discussion:267-9
6. K. Fujioka, K. Esato, N. Zempo, T. Katoh, Y. Fujimura, K. Yoshimura Arterial reconstruction: justified for patients with intermittent claudication? World J Surg 22 1998 1039 1042
7. T.S. Jmsén, H.I. Manninen, H.E. Tulla, P.A. Jaakkola, P.J. Matsi Infrainguinal revascularization because of claudication: total long-term outcome of endovascular and surgical treatment J Vasc Surg 37 2003 808 815
8. E.C. Scott, A. Biuckians, R.E. Light, C.D. Scibelli, T.P. Milner, G.H. Meier 3rd Subintimal angioplasty for the treatment of claudication and critical limb ischemia: 3-year results J Vasc Surg 46 2007 959 964
9. S.M. Taylor, C.A. Kalbaugh, M.G. Healy, A.L. Cass, B.H. Gray, E.M. Langan 3rd Do current outcomes justify more liberal use of revascularization for vasculogenic claudication? A single center experience of 1,000 consecutively treated limbs J Am Coll Surg 206 2008 1053 1062 Discussion:1062-4
10. E.S. van der Zaag, D.A. Legemate, M.H. Prins, J.A. Reekers, M.J. Jacobs Angioplasty or bypass for superficial femoral artery disease? A randomised controlled trial Eur J Vasc Endovasc Surg 28 2004 132 137
11. J. Holm, B. Arfvidsson, L. Jivegrd, F. Lundgren, K. Lundholm, T. Scherstén Chronic lower limb ischaemia A prospective randomised controlled study comparing the 1-year results of vascular surgery and percutaneous transluminal angioplasty (PTA) Eur J Vasc Surg 5 1991 517 522
12. G.L. Wolf, S.E. Wilson, A.P. Cross, R.H. Deupree, W.B. Stason Surgery or balloon angioplasty for peripheral vascular disease: a randomized clinical trial Principal investigators and their Associates of Veterans Administration Cooperative Study Number 199 J Vasc Interv Radiol 4 1993 639 648
13. C.A. Kalbaugh, S.M. Taylor, D.W. Blackhurst, M.B. Dellinger, E.A. Trent, J.R. Youkey One-year prospective quality-of-life outcomes in patients treated with angioplasty for symptomatic peripheral arterial disease J Vasc Surg 44 2006 296 302 Discussion:302-3
14. B.G. DeRubertis, P.L. Faries, J.F. McKinsey, R.A. Chaer, M. Pierce, J. Karwowski Shifting paradigms in the treatment of lower extremity vascular disease: a report of 1000 percutaneous interventions Ann Surg 246 2007 415 422 Discussion:422-4
15. P.J. Matsi, H.I. Manninen, H.K. Sder, P. Mustonen, J. Kouri Percutaneous transluminal angioplasty in femoral artery occlusions: primary and long-term results in 107 claudicant patients using femoral and popliteal catheterization techniques Clin Radiol 50 1995 237 244
16. J.A. Dormandy, R.B. Rutherford Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consens (TASC) J Vasc Surg 31 1 Pt 2 2000 S1 S296
17. L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, F.G. Fowkes TASC II Working Group Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) J Vasc Surg 45 Suppl S 2007 S5 S67
18. M.F. Conrad, R.P. Cambria, D.H. Stone, D.C. Brewster, C.J. Kwolek, M.T. Watkins Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series J Vasc Surg 44 2006 762 769
19. M. Rabellino, T. Zander, S. Baldi, L. Garcia Nielsen, F.J. Aragon-Sanchez, I. Zerolo Clinical follow-up in endovascular treatment for TASC CD lesions in femoro-popliteal segment Catheter Cardiovasc Interv 73 2009 701 705
20. D.T. Baril, R.A. Chaer, R.Y. Rhee, M.S. Makaroun, L.K. Marone Endovascular interventions for TASC II D femoropopliteal lesions J Vasc Surg 51 2010 1406 1412
21. R.B. Rutherford, J.D. Baker, C. Ernst, K.W. Johnston, J.M. Porter, S. Ahn Recommended standards for reports dealing with lower extremity ischemia: revised version J Vasc Surg 26 1997 517 538
22. K.A. Giles, F.B. Pomposelli, T.L. Spence, A.D. Hamdan, S.B. Blattman, H. Panossian Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic Intersociety Consensus class to outcome in 176 limbs J Vasc Surg 48 2008 128 136
23. C.S. Joels, J.W. York, C.A. Kalbaugh, D.L. Cull, E.M. Langan 3rd, S.M. Taylor Surgical implications of early failed endovascular intervention of the superficial femoral artery J Vasc Surg 47 2008 562 565
24. M. Lepntalo, K. Laurila, W.D. Roth, P. Rossi, J. Lavonen, K. Mkinen PTFE bypass or thrupass for superficial femoral artery occlusion? A randomised controlled trial Eur J Vasc Endovasc Surg 37 2009 578 584
25. K. McQuade, D. Gable, G. Pearl, B. Theune, S. Black Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease J Vasc Surg 52 2010 584 590 Discussion:590-1:591.e1-591.e7
26. J.K. Plenge, T.L. Hernandez, K.M. Weil, P. Poirier, G.K. Grunwald, S.M. Marcovina Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction Circulation 106 2002 1447 1452
27. F. Otsuka, K. Hibi, I. Kusama, M. Endo, M. Kosuge, N. Iwahashi Impact of statin pretreatment on the incidence of plaque rupture in ST-elevation acute myocardial infarction Atherosclerosis 213 2010 505 511
28. P.K. Henke, S. Blackburn, M.C. Proctor, J. Stevens, D. Mukherjee, S. Rajagopalin Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality J Vasc Surg 39 2004 357 365
29. T.A. Abbruzzese, J. Havens, M. Belkin, M.C. Donaldson, A.D. Whittemore, J.K. Liao, M.S. Conte Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts J Vasc Surg 39 2004 1178 1185
30. A. Schanzer, N. Hevelone, C.D. Owens, J.A. Beckman, M. Belkin, M.S. Conte Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia J Vasc Surg 47 2008 774 781
31. A.H. Momsen, M.B. Jensen, C.B. Norager, M.R. Madsen, T. Vestersgaard-Andersen, J.S. Lindholt Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomized controlled studies Eur J Vasc Endovasc Surg 38 2009 463 474
32. E.R. Mohler 3rd, W.R. Hiatt, M.A. Creager Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease Circulation 108 2003 1481 1486